Top

Published in:

01-07-2018 | Case report

A case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette–Guérin successfully treated with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage

Authors: Daichi Morooka, Naotaka Nishiyama, Yoshiki Hiyama, Naoya Masumori

Published in: International Cancer Conference Journal | Issue 3/2018

Abstract

We report a case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette–Guérin (BCG) that was successfully treated non-surgically. A 56-year-old man was diagnosed with non-muscle invasive bladder cancer. He was treated with intravesical BCG instillation after transurethral resection of the bladder tumor. Just before the 6th course of intravesical BCG, the patient was diagnosed with bladder perforation and developed ureteral obstruction and sepsis associated with BCG. He was treated successfully with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage. Bladder perforation associated with BCG is a very rare adverse event that causes severe sepsis.

Böhle A, Jocham D, Bock PR (2003) Intravesical bacillus Calmette–Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 169:90–95CrossRefPubMed

Pan J, Liu M, Zhou X (2014) Can intravesical bacillus Calmette–Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis. Front Med 8:241–249CrossRefPubMed

Hinotsu S, Akaza H, Naito S et al (2011) Maintenance therapy with bacillus Calmette–Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer. BJU Int 108:187–195CrossRefPubMed

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2018 available on http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/. Accessed 6 Mar 2018

NCCN Clinical Practice Guidelines in Oncology Testicular Cancer Version 2. 2018 available on https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed 6 Mar 2018

Brausi M, Oddens J, Sylvester R et al (2014) Side effects of Bacillus Calmette–Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol 65:69–76CrossRefPubMed

van der Meijden AP, Sylvester RJ, Oosterlinck W et al (2003) Maintenance Bacillus Calmette-increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial. Eur Urol 44:429–434CrossRefPubMed

Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F et al (2014) Bacillus Calmette–Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore) 93:236–254CrossRefPubMedCentral

Gregg JR, McCormick B, Wang L et al (2016) Short term complications from transurethral resection of bladder tumor. Can J Urol 23:8198–8203PubMed

10.

Mizumura N, Okumura S, Toyoda S et al (2016) Non-traumatic bladder rupture showing less than 10 Hounsfield units of ascites. Acute Med Surg 4:184–189CrossRefPubMedPubMedCentral

11.

Zhan C, Maria PP, Dym RJ et al (2017) Intraperitoneal urinary bladder perforation with pneumoperitoneum in association with indwelling Foley Catheter diagnosed in emergency department. J Emerg Med 53:e93–e96PubMedCrossRef

12.

Fazlioglu A, Tandogdu Z, Kurtulus FO, Parlakkilic O, Cek M (2009) Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant! Urol Int 83:362–363CrossRefPubMed

13.

Lim D, Izawa JI, Middlebrook P, Chin JL (2010) Bladder perforation after immediate postoperative intravesical instillation of mitomycin C. Can Urol Assoc J 4:E1–E3CrossRefPubMedPubMedCentral

14.

Koya MP, Simon MA, Soloway MS (2006) Complications of intravesical therapy for urothelial cancer of the bladder. J Urol 175:2004–2010CrossRefPubMed

15.

Macleod LC, Ngo TC, Gonzalgo ML. Complications of intravesical bacillus Calmette–Guérin. Can Urol Assoc J 8: E540-42014

16.

WHO (2009) Treatment of tuberculosis guidelines, 4th edn. World Health Organization, Geneva (WHO/HTM/TB/2009.420)

17.

Gomez RG, Ceballos L, Coburn M, Corriere JN Jr, Dixon CM, Lobel B, McAninch J (2004) Consensus statement on bladder injuries. BJU Int 94:27–32CrossRefPubMed

18.

Eswara JR, Raup VT, Potretzke AM, Hunt SR, Brandes SB (2015) Outcomes of iatrogenic genitourinary injuries during colorectal surgery. Urology 86:1228–1233CrossRefPubMed

Title: A case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette–Guérin successfully treated with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage
Authors: Daichi Morooka
Naotaka Nishiyama
Yoshiki Hiyama
Naoya Masumori
Publication date: 01-07-2018
Publisher: Springer Japan
Published in: International Cancer Conference Journal / Issue 3/2018
Electronic ISSN: 2192-3183
DOI: https://doi.org/10.1007/s13691-018-0331-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

A cadaveric demonstration of visualization of the urethra using a lighted stent during transanal intersphincteric resection

Guillain–Barré syndrome in a cancer patient treated with bevacizumab

Pathologic complete response after gemcitabine and S-1 chemotherapy for far advanced intrahepatic cholangiocarcinoma

Endoscopic self-expandable metal stent placement for malignant afferent loop obstruction caused by peritoneal recurrence after total gastrectomy

Pyoderma gangrenosum after radical prostatectomy: case report

A case of rapidly progressing prostate cancer diagnosed 20 months after holmium laser enucleation of the prostate

Keynote webinar | Spotlight on antibody–drug conjugates in cancer